Capital Planning Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,048
Closed -$238K 144
2023
Q4
$238K Buy
1,048
+3
+0.3% +$630 0.05% 122
2023
Q3
$210K Sell
1,045
-171
-14% -$36.1K 0.04% 119
2023
Q2
$252K Buy
+1,216
New +$236K 0.05% 117

Other funds holding LH

Capital Planning Advisors's LH Position: Q1 2024 in Review

Capital Planning Advisors sold out of Labcorp (LH) in Q1 2024, closing a stake of 1,048 shares — an estimated $238K sold.

Capital Planning Advisors first reported a position in LH in Q2 2023 and held it in 3 quarters. The position peaked at $252K in Q2 2023. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Capital Planning Advisors reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
  • Capital Planning Advisors sold 1,048 Labcorp shares in Q1 2024, an estimated $238K.
  • Capital Planning Advisors first reported a position in Labcorp in Q2 2023 and held it in 3 quarters.
  • Capital Planning Advisors's Labcorp position peaked at $252K in Q2 2023.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Capital Planning Advisors's 13F filing for Q1 2024, filed 15 May 2024.